Capital Markets & Deal Making 2024 Expectations

Capital Markets & Deal-Making 2024 Expectations: A Beaming Horizon of Opportunity, Innovation, Investments, and Partnerships
Tuesday 20th February 2024
2:00 PM GMT
A panel discussion with:
Jane Buus Laursen, Corporate VP, Business Development, Novo Nordisk
Michael Rice, Founding Partner, LifeSci Advisors
Tim Haines, Managing Director, Abingworth
Marta Helena Lesko, VP Business Development, Merck
Ajan Reginald, CEO, Roquefort Therapeutics
2024 kicked off with a bang at JPM24 and the aftermath has left the healthcare and life sciences sector buzzing with enthusiasm. Several large acquisitions were announced, new funds were launched, and the consensus among the community was that dark skies over biopharma are clearing.
This webinar promises an insightful journey into the promising developments that are shaping the future of life sciences, uncovering a horizon rich with opportunities for growth, groundbreaking innovation, strategic investments, and collaborative partnerships. Join our esteemed panellists as they delve into the transformative trends that are propelling the industry forward, creating a beacon of optimism and potential for stakeholders across the spectrum.
Early signs of a positive trajectory and expectations for public markets and private investments
Market recovery and rejuvenation; M&A, partnerships, and fresh funds
Reinforcing the importance of strategic collaborations and approaching investors in 2024